fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Bavarian Nordic receives EMA approval of Mpox vaccine for adolescents – Bavarian Nordic

Written by | 29 Sep 2024

Bavarian Nordic A/S announced  that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II variation… read more.

Positive CHMP opinion for including Mpox real-world effectiveness data in European Marketing Authorization for smallpox and Mpox vaccine – Bavarian Nordic

Written by | 4 Aug 2024

Bavarian Nordic A/S announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of a type II… read more.

Electronic medical record tool helps clinicians diagnose mpox

Written by | 10 Apr 2024

Diagnosing infectious conditions can be challenging. Diagnosis is especially challenging for uncommon and emerging infectious diseases for which there’s limited clinical experience. Nevertheless, successfully identifying patients with infectious… read more.

Previous smallpox vaccine provides immunity to mpox

Written by | 26 May 2023

Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers from Karolinska Institutet in Sweden report in a study published… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.